Healthy Clinical Trial
Official title:
Imaging Neural Mechanisms Underlying Pain Modulation
This study will evaluate brain pathways involved in feeling pain and pain relief following
administration of pain medication. Magnetic resonance imaging (MRI) will be used to measure
brain activity at sites that become more active following oral surgery and then to see if
the activity changes after pain medication is administered. MRI combines a powerful magnet
with an advanced computer system and radio waves to produce detailed pictures of organs and
tissues. During the scan, the subject lies on a table in a narrow cylinder containing a
magnetic field. He or she can speak with a staff member via an intercom system at all times
during the procedure.
Healthy dental patients recruited through the NIH Clinical Research Volunteer Program may
enroll in this study. Participants will undergo the following tests and procedures in two
clinic visits:
Visit 1 - Sensitivity Testing
Participants are tested for sensitivity to warm and hot temperatures. A probe is applied to
the skin (usually the forearm) and heated to temperatures ranging from room temperature to
that of a hot cup of coffee. Participants rate the temperature using a scale ranging from
"no pain" to the "worst pain imaginable" and rate the unpleasantness of the heat using a
similar scale. The probe is applied up to 30 times, using random heat intensities.
Participants are also asked compare the heat intensity to varying levels of sounds and to
rate the magnitude of different sensations they have experienced in the past, such as the
brightness of the sun and the loudness of a jet plane. A blood sample of about 2 ounces is
also collected at this visit for DNA analysis to look for genes related to pain.
Visit 2 - Oral Surgery
Under local anesthetic, participants undergo extraction of their lower right wisdom tooth.
After surgery, the patient is moved to the MRI scanner for brain imaging over 1-2 hours
while the local anesthetic wears off. Patients may request a postoperative pain drug
(Toradol) during the procedure, if needed. When the scan is complete, patients are dismissed
from the clinic with additional pain medication (flurbiprofen) to use at home as directed.
Functional neuroimaging provides a powerful tool for understanding how the brain may be involved in the perception of pain. It has made it possible to identify areas of the brain that are involved in the perception of experimental pain but very few studies have evaluated the sites in the brain that are activated during clinical pain and the effects of analgesic drugs. The proposed study will use the surgical removal of an impacted third molar as a model of acute clinical pain to identify sites that are activated following the offset of local anesthesia and to examine the effects of the NSAID analgesic ketorolac on attenuating sites that are activated as pain is relieved. Scans will be performed under non-pain baseline conditions, and again immediately following surgery as the local anesthetic wears off, clinical pain occurs, and following administration of the NSAID ketorolac. Differences among subjects in the amount of pain reported and brain activation will be compared to subjects' prior ratings of experimental pain and the presence of any genetic polymorphisms that are related to pain perception, inflammation, known pain pathways, or psychological factors related to pain. The findings from this research may help to reveal how pain is appreciated in the central nervous system, pharmacologically modified by NSAID analgesics and differs among individuals due to genetic factors. ;
Endpoint Classification: Safety/Efficacy Study, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |